ANDA 205926, held by Pharmazone. Prasugrel Hydrochloride.
As of Nov 15, 2026, ANDA 205926 (Prasugrel), held by Pharmazone, was first approved by FDA on Jul 7, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 7, 2020 | Original application | Approved | None posted |
| PrasugrelEQ 5MG BASE · tablet;oral | Prasugrel Hydrochloride | Discontinued |
| PrasugrelEQ 10MG BASE · tablet;oral | Prasugrel Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
